Blood-brain distribution of morphine-6-glucuronide in sheep
Date
2006
Authors
Villesen, H.
Foster, D.
Upton, R.
Christrup, L.
Somogyi, A.
Martinez, A.
Grant, C.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
British Journal of Pharmacology, 2006; 149(6):754-760
Statement of Responsibility
H H Villesen, D J R Foster, R N Upton, L L Christrup, A A Somogyi, A Martinez and C Grant
Conference Name
Abstract
Background and purpose: At present there are few data regarding the rate and extent of brain–blood partitioning of the opioid active metabolite of morphine, morphine-6-glucuronide (M6G). In this study the cerebral kinetics of M6G were determined, after a short-term intravenous infusion, in chronically instrumented conscious sheep. Experimental approach: Five sheep received an intravenous infusion of M6G 2.2 mg kg-1 over a four-minute period. Non-linear mixed-effects analysis, with hybrid physiologically based kinetic models, was used to estimate cerebral kinetics from the arterio-sagittal sinus concentration gradients and cerebral blood flow measurements. Key results: A membrane limited model was selected as the final model. The blood-brain equilibration of M6G was relatively slow (time to reach 50% equilibration of the deep compartment 5.8 min), with low membrane permeability (PS, population mean, 2.5 ml min-1) from the initial compartment (V1, 13.7 ml) to a small deep distribution volume (V2) of 18.4 ml. There was some between-animal variability (%CV) in the initial distribution volume (29%), but this was not identified for PS or V2. Conclusion and Implications: Pharmacokinetic modelling of M6G showed a delayed equilibration between brain and blood of a nature that is primarily limited by permeability across the blood-brain-barrier, in accordance with its physico-chemical properties.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright status unknown